Characterization reveals frdA mutations reduce pathogenicity in Salmonella, suggesting potential for vaccine development.
Background Salmonella has the ability to adapt to variable environments by modulating metabolism. The Tricarboxylic Acid Cycle (TCA), as a core metabolic process, is critical for the environmental adaptation and infection process of Salmonella . Fumarate reductase FrdA is an important enzyme in the TCA cycle, mainly catalyzing the conversion of fumarate to succinate. But the association between this enzyme and the pathogenicity of Salmonella has not yet been reported. Methods To determine the role of fumarate reductase FrdA in Salmonella infection, a frdA -gene deletion strain of Salmonella enteritidis ( S. enteritidis ) was generated in this study, and the effect of frdA knockout on the biological properties and pathogenicity of S . enteritidis were further examined. Then, the immunoprotective effect of frdA -deficient strain was determined. Results The results showed that frdA deletion did not affect the growth properties of S. enteritidis but caused a significant decreased survival under environmental stress, as well as a substantial decrease in its motility and biofilm formation ability. The Δ frdA mutant displayed apparently reduced adhesion and invasion to Caco-2 cells and markedly impaired survival and replication in RAW264.7 cells. The animal infection test showed that the frdA gene deletion could lead to a significant decrease in virulence of S. enteritidis in mice, with a 64-fold increased LD 50 for mice, and Δ frdA demonstrated significantly decreased colonization in mouse tissues and organs. The transcriptomics results showed that frdA deletion resulted in altered expression of 2163 genes in S. enteritidis , and downregulated expression of csgD and other virulence genes were confimed by qPCR. Moreover, immunization of mice with the frdA deletion strain provided promising immune protection for mice. Conclusion Fumarate reductase FrdA is closely associated with pathogenicity of S. enteritidis and that is an attractive candidate target for vaccine design of Salmonella .
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: